(R)-N-(3-(1H-tetrazol-5-yl)benzyl)-3-cyclohexyl-2-(3-(2-(3,4-dimethoxyphenyl)acetyl)guanidino)propanamide

ID: ALA3321932

Chembl Id: CHEMBL3321932

PubChem CID: 90285319

Max Phase: Preclinical

Molecular Formula: C28H36N8O4

Molecular Weight: 548.65

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(CC(=O)NC(=N)N[C@H](CC2CCCCC2)C(=O)NCc2cccc(-c3nnn[nH]3)c2)cc1OC

Standard InChI:  InChI=1S/C28H36N8O4/c1-39-23-12-11-19(15-24(23)40-2)16-25(37)32-28(29)31-22(14-18-7-4-3-5-8-18)27(38)30-17-20-9-6-10-21(13-20)26-33-35-36-34-26/h6,9-13,15,18,22H,3-5,7-8,14,16-17H2,1-2H3,(H,30,38)(H3,29,31,32,37)(H,33,34,35,36)/t22-/m1/s1

Standard InChI Key:  DJZAYIHRUXCKNB-JOCHJYFZSA-N

Associated Targets(Human)

REN Tclin Renin (5251 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSD Tchem Cathepsin D (3201 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

CTSD Cathepsin D (510 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 548.65Molecular Weight (Monoisotopic): 548.2860AlogP: 2.72#Rotatable Bonds: 11
Polar Surface Area: 167.00Molecular Species: ACIDHBA: 8HBD: 5
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 4.29CX Basic pKa: 8.22CX LogP: 2.15CX LogD: 2.11
Aromatic Rings: 3Heavy Atoms: 40QED Weighted: 0.18Np Likeness Score: -0.82

References

1. Grädler U, Czodrowski P, Tsaklakidis C, Klein M, Werkmann D, Lindemann S, Maskos K, Leuthner B..  (2014)  Structure-based optimization of non-peptidic Cathepsin D inhibitors.,  24  (17): [PMID:25086681] [10.1016/j.bmcl.2014.07.054]

Source